IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Novo Holdings A/S

Q2 2026 Holdings

Filed 2026-08-14 | 25 holdings | $1.7B | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Edgewise Therapeutics Inc(EWTX)COM28036F105$217.4M5,350,00012.6%
Asml Holding N V(ASML)N Y REGISTRY SHSN07059210$188.9M94,94611.0%
Hemab Therapeutics Hldgs Inc(COAG)COM SHS423494103$153.6M4,180,5508.9%
Brookfield Corp(BN)CL A LTD VT SH11271J107$149.5M3,496,2458.7%
Maplight Therapeutics Inc(MPLT)COM56565P103$132.1M3,686,6227.7%
Mirum Pharmaceuticals Inc(MIRM)COM604749101$131.7M1,125,0007.6%
Avalyn Pharmaceuticals Inc(AVLN)COM SHS05348Y105$127.8M3,883,2897.4%
Salesforce Inc(CRM)COM79466L302$61.6M393,1873.6%
Arrivent Biopharma Inc(AVBP)COM04272N102$52.1M1,500,0003.0%
Enliven Therapeutics Inc(ELVN)COM29337E102$50.8M1,000,0002.9%
Crinetics Pharmaceuticals in(CRNX)COM22663K107$49.4M1,320,0002.9%
Pharvaris N V(PHVS)COMN69605108$48.4M1,400,0002.8%
Floor & Decor Hldgs Inc(FND)CL A339750101$47.3M797,0002.7%
Vaxcyte Inc(PCVX)COM92243G108$46.5M800,0002.7%
4D Molecular Therapeutics in(FDMT)COM35104E100$43.2M3,249,1782.5%
Viridian Therapeutics Inc(VRDN)COM92790C104$39.2M2,135,0002.3%
Celldex Therapeutics Inc New(CLDX)COM NEW15117B202$38.1M1,025,0002.2%
Alumis Inc(ALMS)COM022307102$31.0M1,100,0001.8%
Xenon Pharmaceuticals Inc(XENE)COM98420N105$29.3M485,4381.7%
Alibaba Group Hldg LTD(BABA)SPONSORED ADS01609W102$24.7M257,3271.4%
Dyne Therapeutics Inc(DYN)COM26818M108$21.3M960,3941.2%
Bridgebio Oncology Therapeut(BBOT)COM NEW107924102$17.1M2,250,0001.0%
Insmed Inc(INSM)COM PAR $.01457669307$12.9M120,7230.7%
Marqeta Inc(MQ)CLASS A COM57142B104$7.2M441,5580.4%
Lanzatech Global Inc(LNZA)COM NEW51655R200$1.1M158,1480.1%